Reik & Co’s AbbVie ABBV Stock Holding History

Reik & Co’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.02M	Hold	4,070	–	–	0.27%	25
2026 Q1	$885K	Hold	4,070	–	–	0.24%	26
2025 Q4	$930K	Sell	4,070 -380	-9%	-$86.6K	0.26%	26
2025 Q3	$1.03M	Hold	4,450	–	–	0.26%	27
2025 Q2	$826K	Hold	4,450	–	–	0.21%	30
2025 Q1	$932K	Sell	4,450 -50	-1%	-$9.72K	0.22%	23
2024 Q4	$800K	Hold	4,500	–	–	0.19%	30
2024 Q3	$889K	Hold	4,500	–	–	0.21%	25
2024 Q2	$772K	Hold	4,500	–	–	0.2%	27
2024 Q1	$819K	Hold	4,500	–	–	0.2%	26
2023 Q4	$697K	Sell	4,500 -620	-12%	-$90.4K	0.2%	30
2023 Q3	$763K	Sell	5,120 -1,878	-27%	-$276K	0.22%	28
2023 Q2	$943K	Hold	6,998	–	–	0.26%	28
2023 Q1	$1.12M	Sell	6,998 -332	-5%	-$50.8K	0.33%	25
2022 Q4	$1.19M	Hold	7,330	–	–	0.34%	23
2022 Q3	$984K	Hold	7,330	–	–	0.32%	25
2022 Q2	$1.12M	Hold	7,330	–	–	0.32%	24
2022 Q1	$1.19M	Hold	7,330	–	–	0.3%	26
2021 Q4	$992K	Hold	7,330	–	–	0.24%	31
2021 Q3	$791K	Hold	7,330	–	–	0.2%	37
2021 Q2	$826K	Hold	7,330	–	–	0.21%	35
2021 Q1	$793K	Hold	7,330	–	–	0.2%	36
2020 Q4	$785K	Buy	+7,330	New	+$704K	0.2%	33
2014 Q3	–	Sell	-6,467	Closed	-$365K	–	56
2014 Q2	$365K	Hold	6,467	–	–	0.12%	48
2014 Q1	$332K	Buy	6,467 +680	+12%	+$34.4K	0.12%	51
2013 Q4	$306K	Buy	+5,787	New	+$284K	0.11%	50

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Reik & Co's ABBV Position: Q2 2026 in Review

Reik & Co held its AbbVie (ABBV) position steady in Q2 2026 at 4,070 shares worth $1.02M. The position accounts for 0.27% of the portfolio, ranked #25.

Reik & Co first reported a position in ABBV in Q4 2013 and has held it in 26 quarters since. The position peaked at $1.19M in Q1 2022. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Reik & Co held 4,070 shares of AbbVie worth $1.02M as of Q2 2026.
Reik & Co left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.27% of Reik & Co's portfolio in Q2 2026, its #25 holding.
Reik & Co first reported a position in AbbVie in Q4 2013 and has held it in 26 quarters since.
Reik & Co's AbbVie position peaked at $1.19M in Q1 2022.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Reik & Co's 13F filing for Q2 2026, filed 10 Aug 2026.